Lindsay Rosenwald
Chairman, President, CEO, Fortress Biotech

Since 2009, Dr. Rosenwald has served as Co-Portfolio Manager and Partner of Opus Point Partners, LLC (‘Opus’), an asset management firm in the life sciences industry.

Prior to that, from 1991 to 2008, he served as the Chairman of Paramount BioCapital, Inc. Over the last 23 years, Dr. Rosenwald has acted as a biotechnology entrepreneur and been instrumental in the founding and recapitalization of numerous public and private biotechnology and life sciences companies.

Dr. Rosenwald received his B.S. in finance from Pennsylvania State University and his M.D. from Temple University School of Medicine.

Claude Maraoui
President & CEO, Journey Medical Corporation

Claude has more than 25 years of experience in commercializing some of the most successful dermatology products in the world.

He served as Vice President of Dermatology Sales at Medicis Pharmaceutical Corporation and has held various leadership positions in marketing and sales for therapeutic and aesthetic dermatology. He has executed more than 50 product launches during his career.

In 2012, Valeant Pharmaceuticals International Inc., acquired Medicis for approximately $2.6B. Claude received his B.S. in business and marketing from Rutgers University.